- Featured Product
- KD/KO Validated
TGFBI / BIGH3 Monoklonaler Antikörper
TGFBI / BIGH3 Monoklonal Antikörper für IF, IHC, IP, WB, ELISA
Wirt / Isotyp
Maus / IgG2a
Getestete Reaktivität
human und mehr (1)
Anwendung
WB, IP, IHC, IF, ELISA
Konjugation
Unkonjugiert
CloneNo.
3E11D11
Kat-Nr. : 60007-1-Ig
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | humanes Nierengewebe |
Erfolgreiche IP | HeLa-Zellen |
Erfolgreiche Detektion in IHC | humanes Kolongewebe, humanes Hautkrebsgewebe, humanes Kolonkarzinomgewebe, humanes Nierengewebe, humanes Plazenta-Gewebe Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen. |
Erfolgreiche Detektion in IF | humanes Kolonkarzinomgewebe |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunhistochemie (IHC) | IHC : 1:500-1:2000 |
Immunfluoreszenz (IF) | IF : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
KD/KO | See 2 publications below |
WB | See 8 publications below |
IHC | See 4 publications below |
IF | See 1 publications below |
IP | See 1 publications below |
Produktinformation
60007-1-Ig bindet in WB, IP, IHC, IF, ELISA TGFBI / BIGH3 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
In Publikationen genannte Reaktivität | human, Maus |
Wirt / Isotyp | Maus / IgG2a |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | TGFBI / BIGH3 fusion protein Ag0241 |
Vollständiger Name | transforming growth factor, beta-induced, 68kDa |
Berechnetes Molekulargewicht | 683 aa, 75 kDa |
Beobachtetes Molekulargewicht | 68 kDa |
GenBank-Zugangsnummer | BC000097 |
Gene symbol | TGFBI |
Gene ID (NCBI) | 7045 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Caprylsäure/Ammoniumsulfat-Präzipitation |
Lagerungspuffer | PBS with 0.1% sodium azide and 50% glycerol pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
TGFBI, also named as BIGH3, Kerato-epithelin and RGD-CAP, binds to type I, II, and IV collagens. TGFBI is an adhesion protein which may play an important role in cell-collagen interactions. In cartilage, it may be involved in endochondral bone formation. TGFBI is an extracellular matrix adaptor protein, it has been reported to be differentially expressed in transformed tissues. TGFBI is a predictive factor of the response to chemotherapy, and suggest the use of TGFBI-derived peptides as possible therapeutic adjuvants for the enhancement of responses to chemotherapy.(PMID:20509890) Defects in TGFBI are the cause of epithelial basement membrane corneal dystrophy (EBMD). Defects in TGFBI are the cause of corneal dystrophy Groenouw type 1 (CDGG1). Defects in TGFBI are the cause of corneal dystrophy lattice type 1 (CDL1). Defects in TGFBI are a cause of corneal dystrophy Thiel-Behnke type (CDTB). Defects in TGFBI are the cause of Reis-Buecklers corneal dystrophy (CDRB). Defects in TGFBI are the cause of lattice corneal dystrophy type 3A (CDL3A). Defects in TGFBI are the cause of Avellino corneal dystrophy (ACD).
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for TGFBI / BIGH3 antibody 60007-1-Ig | Protokoll herunterladen |
IHC protocol for TGFBI / BIGH3 antibody 60007-1-Ig | Protokoll herunterladen |
IF protocol for TGFBI / BIGH3 antibody 60007-1-Ig | Protokoll herunterladen |
IP protocol for TGFBI / BIGH3 antibody 60007-1-Ig | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
Cancer Res TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer. | ||
Int J Cancer Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. | ||
Cell Mol Life Sci TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions. | ||
Front Oncol Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics Analysis. | ||
Neoplasia BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
| ||
PLoS One Absence of Vitamin K-Dependent γ-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize γ-Carboxylation. |